Literature DB >> 10652218

Differential regulation of melanin-concentrating hormone and orexin genes in the agouti-related protein/melanocortin-4 receptor system.

R Hanada1, M Nakazato, S Matsukura, N Murakami, H Yoshimatsu, T Sakata.   

Abstract

Agouti protein and agouti-related protein (AGRP) antagonize alpha-melanocyte-stimulating hormone that binds to and activates the melanocortin-4 receptor (MC4-R) in the hypothalamus, thereby stimulating food intake. Melanin-concentrating hormone (MCH) and orexin are orexigenic peptides that specifically are synthesized in the lateral hypothalamus. MCH gene expression was augmented in A(y)/a (agouti) mice which overexpress agouti protein, but orexin mRNA was not. AGRP administered intracerebroventricularly into wild-type rats augmented MCH but not orexin gene expression. Also, SHU9119, a peptidergic antagonist of MC4-R, increased only MCH mRNA. These findings indicate that interruption of signaling at MC4-R activates the MCH but not the orexin gene. The biosyntheses of MCH and orexin are regulated through different pathways. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10652218     DOI: 10.1006/bbrc.1999.2081

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  15 in total

Review 1.  Integration of reward signalling and appetite regulating peptide systems in the control of food-cue responses.

Authors:  A C Reichelt; R F Westbrook; M J Morris
Journal:  Br J Pharmacol       Date:  2015-11-01       Impact factor: 8.739

Review 2.  Hypothalamic regulatory pathways and potential obesity treatment targets.

Authors:  Erin E Jobst; Pablo J Enriori; Puspha Sinnayah; Michael A Cowley
Journal:  Endocrine       Date:  2006-02       Impact factor: 3.633

Review 3.  Estradiol signaling in the regulation of reproduction and energy balance.

Authors:  Kevin Sinchak; Edward J Wagner
Journal:  Front Neuroendocrinol       Date:  2012-09-07       Impact factor: 8.606

Review 4.  The MC4 receptor and control of appetite.

Authors:  R A H Adan; B Tiesjema; J J G Hillebrand; S E la Fleur; M J H Kas; M de Krom
Journal:  Br J Pharmacol       Date:  2006-10-16       Impact factor: 8.739

5.  Direct innervation and modulation of orexin neurons by lateral hypothalamic LepRb neurons.

Authors:  Gwendolyn W Louis; Gina M Leinninger; Christopher J Rhodes; Martin G Myers
Journal:  J Neurosci       Date:  2010-08-25       Impact factor: 6.167

Review 6.  Melanocortin control of energy balance: evidence from rodent models.

Authors:  Bart C De Jonghe; Matthew R Hayes; Kendra K Bence
Journal:  Cell Mol Life Sci       Date:  2011-05-08       Impact factor: 9.261

7.  Control of food intake by MC4-R signaling in the lateral hypothalamus, nucleus accumbens shell and ventral tegmental area: interactions with ethanol.

Authors:  Jose M Lerma-Cabrera; Francisca Carvajal; Lourdes de la Torre; Leticia de la Fuente; Montserrat Navarro; Todd E Thiele; Inmaculada Cubero
Journal:  Behav Brain Res       Date:  2012-06-17       Impact factor: 3.332

8.  Hypothalamic melanin-concentrating hormone and estrogen-induced weight loss.

Authors:  P Mystkowski; R J Seeley; T M Hahn; D G Baskin; P J Havel; A M Matsumoto; C W Wilkinson; K Peacock-Kinzig; K A Blake; M W Schwartz
Journal:  J Neurosci       Date:  2000-11-15       Impact factor: 6.167

9.  Mice lacking pro-opiomelanocortin are sensitive to high-fat feeding but respond normally to the acute anorectic effects of peptide-YY(3-36).

Authors:  B G Challis; A P Coll; G S H Yeo; S B Pinnock; S L Dickson; R R Thresher; J Dixon; D Zahn; J J Rochford; A White; R L Oliver; G Millington; S A Aparicio; W H Colledge; A P Russ; M B Carlton; S O'Rahilly
Journal:  Proc Natl Acad Sci U S A       Date:  2004-03-15       Impact factor: 11.205

10.  Blockade of MCH1 receptor signalling ameliorates obesity and related hepatic steatosis in ovariectomized mice.

Authors:  A Gomori; A Ishihara; M Ito; H Matsushita; M Ito; S Mashiko; H Iwaasa; M Matsuda; M A Bednarek; S Qian; D J Macneil; A Kanatani
Journal:  Br J Pharmacol       Date:  2007-05-21       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.